Tag Archives: stumbles

Cyberpunk 2077 player stumbles across main menu easter egg hidden in plain sight, dev says ‘I started to doubt you chooms will ever find it’ – PC Gamer

  1. Cyberpunk 2077 player stumbles across main menu easter egg hidden in plain sight, dev says ‘I started to doubt you chooms will ever find it’ PC Gamer
  2. For the second time in a week, a Cyberpunk 2077 Easter egg has been found that the devs had “started to doubt” would ever be discovered Gamesradar
  3. Cyberpunk 2077 player uncovers brand-new secret in game’s latest update GAMINGbible
  4. CD Projekt dev congratulates Cyberpunk 2077 player on finding an Easter egg photobomb after the RPG’s latest update Gamesradar
  5. Cyberpunk 2077: Super Secret Easter Egg Finally Discovered IGN

Read original article here

Box Office: Hayao Miyazaki’s ‘The Boy and the Heron’ Opens to Record-Breaking $12.8 Million, Beyoncé’s ‘Renaissance’ Stumbles in Second Weekend – Variety

  1. Box Office: Hayao Miyazaki’s ‘The Boy and the Heron’ Opens to Record-Breaking $12.8 Million, Beyoncé’s ‘Renaissance’ Stumbles in Second Weekend Variety
  2. Miyazaki’s ‘The Boy and the Heron’ is No. 1 at the box office, a first for the Japanese anime master The Associated Press
  3. The Boy and the Heron Review GameRant
  4. The Boy and the Heron voice director doubted Robert Pattinson’s casting Dexerto
  5. Weekend Box Office: The Boy and the Heron becomes Miyazaki’s best while Beyoncé falls hard JoBlo.com

Read original article here

Taylor Swift Box Office: Lessons Learned From ‘Eras Tour’ Rollout Stumbles – Hollywood Reporter

  1. Taylor Swift Box Office: Lessons Learned From ‘Eras Tour’ Rollout Stumbles Hollywood Reporter
  2. Taylor Swift’s ‘Eras Tour’ Film Ignites Debate Over Movie Theater Etiquette Yahoo Entertainment
  3. 10 Reasons Taylor Swift: The Eras Tour’s Box Office Is So Impressive: Breaking Down The $123M Opening Screen Rant
  4. “Taylor Swift: The Eras Tour” Is Intimate, Colossal, and Slightly Disappointing The New Yorker
  5. Taylor Swift: The Eras Tour Movie Review: A Flawless, Spectacular Must-See! A Concert Film Like No Other, For A Pop Star Like No Other Koimoi
  6. View Full Coverage on Google News

Read original article here

‘The Flash’ Stumbles at International Box Office With $75 Million, Pixar’s ‘Elemental’ Crashes With $15 Million Overseas – Variety

  1. ‘The Flash’ Stumbles at International Box Office With $75 Million, Pixar’s ‘Elemental’ Crashes With $15 Million Overseas Variety
  2. Does The Flash Deserve Its Rotten Tomatoes Score? MovieWeb
  3. Box Office: Ezra Miller’s ‘The Flash,’ Pixar’s ‘Elemental’ Get Iced in Openings Yahoo Entertainment
  4. ‘The Flash’ Disappoints With $55 Million Debut, Pixar’s ‘Elemental’ Flops With $29.5 Million in Battle of Box Office Lightweights Variety
  5. Why The Flash’s Rotten Tomatoes Audience Score Dropped So Much Screen Rant
  6. View Full Coverage on Google News

Read original article here

Wall St stumbles after weak data, hawkish Fed comments

  • Fed’s Bullard, Mester back rate increases
  • U.S. retail sales drop in December
  • Indexes down: Dow 1.28%, S&P 1.07%, Nasdaq 0.78%

Jan 18 (Reuters) – Wall Street’s main indexes fell on Wednesday after weak economic data and hawkish comments from Federal Reserve officials sparked worries that the central bank may not pause interest rate hikes any time soon.

Before the market opened, U.S. economic data showed retail sales and producer prices declined more than expected in December. Also production at U.S. factories fell more than expected in December and output in the prior month was weaker than previously thought.

With Wall Street’s major averages showing gains so far for 2023, Sam Stovall, chief investment strategist at CFRA research, said some investors saw the week data as an opportunity to take profits while others worried about the prospects for a recession.

“The market was overbought. Today’s economic data served as a trigger to initiate a profit taking spell and the groups with most profits to take have been the ones that have done best last year,” said Stovall.

By 2:14PM ET, the Dow Jones Industrial Average (.DJI) fell 434.27 points, or 1.28%, to 33,476.58, the S&P 500 (.SPX) lost 42.57 points, or 1.07%, to 3,948.4 and the Nasdaq Composite (.IXIC) dropped 87.02 points, or 0.78%, to 11,008.10.

The weakest sectors on the day are the defensive consumer staples (.SPLRCD), down more than 2%, and utilities (.SPLRCU), which was last down 1.8%.

The benchmark S&P and the blue-chip Dow were both on track for their second straight day of losses, while the Nasdaq, if it ends lower, would snap a seven-day winning streak.

U.S. stocks had started 2023 on a strong footing, with the S&P having closed up almost 4% year-to-date on Tuesday, on hopes that a moderation in inflationary pressures could give the Fed cover to dial down the size of its interest rate hikes.

Roughly halfway through January, the S&P was up 2.7% for the month so far while the Nasdaq was up more than 5% and the Dow, the best performer of the three for 2022, was up 0.9%.

Earlier, St. Louis Fed President James Bullard and Cleveland Fed President Loretta Mester stressed on the need to raise rates beyond 5% to bring inflation to heel.

The Fed commentary also highlighted the disparity between the U.S. central bank’s estimate of its terminal rate and market expectations, which were of the rate peaking at 4.88% by June. Traders are now betting on a 25-basis point rate hike in February.

“This market is very hopeful that we’re going to get a soft landing and every time you have hawkish comments from the Fed, it feels you’re not going to get that,” Dennis Dick, trader at Triple D Trading.

Investors are also focused on the fourth-quarter earnings season as a window into how corporate America is doing against the backdrop of higher interest rates.

Analysts now expect year-over-year earnings from S&P 500 companies to decline 2.6% for the quarter, according to Refinitiv data, compared with a 1.6% decline in the beginning of the year.

IBM Corp (IBM.N) was down 2.6% after Morgan Stanley downgraded the company’s shares to “equal weight” from “overweight”.

Early gainers Microsoft Corp (MSFT.O) and Tesla Inc (TSLA.O) erased gains by late afternoon trading with Microsoft down 1.2% and Tesla off 2.7%.

Moderna Inc (MRNA.O) rose 3.6% after reporting data which demonstrated the effectiveness of its respiratory syncytial virus (RSV) vaccine.

PNC Financial Services Group Inc (PNC.N) was down 5.4% after the company missed estimates for fourth-quarter profit.

Declining issues outnumbered advancing ones on the NYSE by a 1.38-to-1 ratio; on Nasdaq, a 1.66-to-1 ratio favored decliners.

The S&P 500 posted 9 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 71 new highs and 14 new lows.

Reporting by Sinéad Carew in New York, Shreyashi Sanyal and Amruta Khandekar in Bengaluru; Additional reporting by Shubham Batra; Editing by Shounak Dasgupta and David Gregorio

Our Standards: The Thomson Reuters Trust Principles.

Read original article here

John Fetterman Stumbles, ‘Stutters’ During Interview, Requires Closed Captioning After May Stroke

With weeks to go before the election, Pennsylvania’s lieutenant governor and Democratic Senate nominee, John Fetterman, is still struggling with the effects of a May stroke.

In his first in-person interview, which aired Tuesday night, Fetterman required the use of closed captioning.

The Democrat is “still suffering from auditory processing issues, which means he has a hard time understanding what he’s hearing,” NBC News reporter Dasha Burns said.

NBC News agreed to the use of closed captioning technology during the interview, where a screen transcribed Burns’ questions.

“I sometimes will hear things in a way that’s not perfectly clear. So I use captioning so I’m able to see what you’re saying on the captioning,” Fetterman said.

Fetterman “occasionally stuttered and had trouble finding words,” according to the report, responding to Burns’ oral questions after subsequently reading the captions on a computer screen. In the interview, Fetterman can clearly be seen behind the screen reading the questions as they come.

“Every now and then I’ll miss a word. Every now and then. Or sometimes I’ll maybe mush two words together. But as long as I have captioning, I’m able to understand exactly what’s being asked,” he said.

In the interview, Fetterman can be seen having difficulty attempting to pronounce the word “empathetic,” moving between “emphetic” and “empathetic” before finally landing on the latter. He then used that as an example of the side affects of the stroke.

Fetterman said he is still in the recovery process but that “I don’t think it’s going to have an impact. I feel like I’m gonna get better and better—every day. And by January, I’m going [to] be, you know, much better. And Dr. Oz is still going to be a fraud.”

Burns said that before the interview and without captioning, “it wasn’t clear he was understanding our conversation.”

When questioned why he would not supply NBC with medical records or make any of his doctors available for an interview, Fetterman replied: “I feel like we have been very transparent in a lot of different ways. When our doctor has already given a letter saying that I’m able to serve and to be running. And then I think there’s—you can’t be any more transparent than standing up on a stage with 3,000 people and having a speech without a teleprompter and just being—and putting everything and yourself out there like that. I think that’s as transparent as everyone in Pennsylvania can see.”

Concerns surrounding Fetterman’s health have run rampant in the lead-up to the November election, with some questioning whether his health and heart are up to the job.

Republicans are already using the footage to their advantage; Steve Guest, special adviser for communications for Sen. Ted Cruz (R-TX), called it a “disaster,” claiming “John Fetterman is not well.”

“No wonder Fetterman has refused to do interviews,” he tweeted. “And this is who Democrats want to be a Senator.”

Former Trump aide Stephen Miller tweeted that “if one was going to elect a new Senator with grave cognitive impediments to performing his duties one would likely want an individual who was in every other way exemplary. Not the crazy, radical, dresses like he’s 11, pro-murderer anti-cop marxist zealot deadbeat John Fetterman.”

Clay Travis of the conservative podcast The Clay Travis and Buck Sexton Show called the interview “insane,” adding, “imagine what media would be saying if a Republican was trying to pull this campaign off.”

Former Fox News contributor and Trump Treasury Department spokeswoman Monica Crowley labeled Fetterman “unfit to serve in the Senate,” criticizing him because he “couldn’t even make it through a basic, friendly interview with MSNBC: couldn’t hear, couldn’t understand.”

Dr. Oz’s team is yet to comment, however senior communications adviser Rachel Tripp told Insider in August: “If John Fetterman had ever eaten a vegetable in his life, then maybe he wouldn’t have had a major stroke and wouldn’t be in the position of having to lie about it constantly.”

When The Daily Beast reached out to Tripp at the time, she replied via email: “Nice try. Dr. Oz has been urging people to eat more veggies for years. That’s not ridicule. It’s good health advice. We’re only trying to help.”

Speaking on The Last Word on Tuesday night, Fetterman criticized Dr. Oz for the comments, saying, “I can’t believe that having a doctor that is cheering on for me not to get better.”

Fetterman still leads in the polls.

The Democrat has used closed captioning technology in interviews before; it was cited in a piece earlier this month in The New Yorker, where he used Google Meet to conduct the interview.

“Because the stroke had made it difficult for him to process what he hears, the video chat has closed captioning technology that allowed him to read my questions in real time,” reporter Rebecca Traister wrote.

Fetterman has agreed to an Oct. 25 debate with his opponent, Republican Mehmet Oz, but under the condition that Fetterman have access to a closed captioning monitor so he can read the questions as they come in.

Political commentator Adam Jentleson said the interview was a “good moment for a gut check here.” He wrote in a tweet: “I’m biased but when I watch the clip I see a guy recovering and recovering overcoming a challenge. I wonder what voters will see.”

Political, public affairs, and communications strategist Jeff Timmer tweeted that it was a “bold but wise” strategy to have Fetterman doing interviews and “showing the accessibility tools he uses to process the spoken word. I commend him and his team for having the guts and balls to do this.”



Read original article here

Guy Stumbles Upon Remains of Massive Dinosaur in His Backyard

An unassuming backyard in central Portugal has turned into an excavation site for the remains of what could be a record-setting dinosaur.  

The excitement started in 2017, when a man in the city of Pombal spotted fragments of fossilized bones while digging up his garden to build an extension. He contacted researchers with the stunning find, and since then, paleontologists have been busy at the site unearthing fossilized fragments of what they believe could be the largest sauropod found in Europe yet.

Sauropods, which count among the biggest animals to have lived on land, had small heads atop long necks, long tails and four thick legs. They roved Earth 150 million years ago, reaching staggering heights of 39 feet (12 meters) and lengths of 82 feet (25 meters).   

Earlier this month, the research team from Portugal and Spain collected vertebrae of the possible brachiosaurid sauropod from the garden, as well as ribs that include a whopper around 10 feet (3 meters) long. The way the fragments are situated leaves the researchers hopeful more reptilian treasures await at the Pombal site.  

“It is not usual to find all the ribs of an animal like this, let alone in this position, maintaining their original anatomical position,” Elisabete Malafaia, a postdoctoral researcher at the Faculty of Sciences of the University of Lisbon, said in a statement. “This mode of preservation is relatively uncommon in the fossil record of dinosaurs, in particular sauropods, from the Portuguese Upper Jurassic.” 

The researchers will continue to excavate in the Pombal garden, and possibly beyond, to better understand the region’s fossil record of Late Jurassic vertebrates. And the owner of the house will no doubt be on high alert next time he goes outside to plant a few perennials.  

Not the typical garden find. 


Faculty of Sciences of the University of Lisbon

Read original article here

US stumbles in monkeypox response

The U.S. has had a faltering response to the monkeypox outbreak, with confirmed cases jumping to 700 in the two months since outbreaks were first detected and clinics across the country struggling to meet the demand for effective vaccines.

Some public health experts and patients say more needs to be done and warn that mistakes made during the COVID-19 pandemic are being repeated. 

The monkeypox virus is less infectious than COVID-19 and is so far mostly affecting one community: men who have sex with men. But the U.S. has learned lessons from the coronavirus pandemic that should still help the nation control monkeypox, experts say. 

Leana Wen, a research professor of health policy and management at George Washington University as well as Baltimore’s former health commissioner, told The Hill that she has felt a sense of déjà vu.

“Probably the most significant one to me is the lack of testing. We saw during COVID that every case that was found was like the canary in the coal mine, that they really were just the tip of the iceberg,” Wen said. “And that was because there was such little testing available. Why haven’t we learned our lesson?”

Last week, one of the largest laboratory testing networks in the U.S., Labcorp, announced it would begin testing for monkeypox using tests from the Centers for Disease Control and Prevention. The company will be able to conduct about 10,000 tests daily.

In its announcement, Labcorp recommended that people contact their health care providers to initiate monkeypox testing and sample collecting, a more cumbersome process compared to COVID-19 tests, especially for people who don’t have a regular health care provider.

Wen said monkeypox testing should not be made into a complex process, noting that performing the test itself is fairly simple: Monkeypox tests involve swabbing the base of the characteristic lesions that form after infection.

More than 760 monkeypox cases have been confirmed in the U.S. as of Monday across almost 40 states, which is almost certainly an undercount as many may be unaware that they are infected or have not yet been tested.

Unlike COVID-19, monkeypox is not a novel virus, it does not spread as easily and is largely transmitted through close, skin-to-skin contact. And although it is currently affecting relatively few people in the U.S., advocates and scientists worry this outbreak may spread out of control.

Jay Varma, an epidemiologist who served as senior health adviser to former New York City Mayor Bill de Blasio (D), said in a recent interview that he feared monkeypox could become entrenched in the U.S.

“If we don’t really get ahead of this, then we are going to fall further behind and it will become a permanent part of our disease landscape,” Varma said.

De Blasio himself urged the federal government to ramp up access to monkeypox vaccines on Twitter Monday. 

New York’s gay community has been particularly hard hit by the outbreak. The state Department of Health said in a tweet on Tuesday that 111 people had tested positive in New York City as of last week, up from 55 a week prior.

New York City Mayor Eric Adams (D) made note of the unmet demand for monkeypox vaccines in a letter he sent to President Biden on Monday. Adams asked that the White House consider a different vaccination schedule that allowed for a longer interval period between the two doses of the preferred smallpox vaccine Jynneos so that more people could be immediately immunized.

In an NBC News report published last week, several gay men who tested positive for monkeypox detailed exasperating experiences in communicating with public health officials when attempting to get tested and share their possible close contacts. One man in New York said it took nearly a week before he was able to get tested and possible contacts’ names.

Clinics in major cities like New York and Washington, D.C., have quickly run out of available vaccine doses. 

New York gave no warning before announcing its own vaccine push late last month, running out of doses within hours with no word on when more shots would be available. On Monday, the New York City Department of Health and Mental Hygiene announced that an additional 1,250 doses would be made available.

Health authorities maintain that monkeypox does not pose a threat to the general public, and the mortality rate for the virus is low.

Eric Toner, a senior scholar at the Johns Hopkins Center for Health Security at the Bloomberg School of Public Health, said that this recent monkeypox outbreak could very well be a sign of an “age of epidemics” that the world is entering.

“As people interact more and more with wild animals — whether it’s in wet markets as food or moving into their habitats because of population growth — we are going to see people get exposed more and more to exotic pathogens,” Toner said.

Overall, Toner said he felt that the response has been adequate considering the limitations, noting the inherent difficulties in measures like contact tracing as well as the swift manner in which the federal government deployed vaccines and placed orders for more.

“I don’t think that they have been slow. I don’t think it’s the case that they haven’t learned lessons from COVID-19,” he said.

Still others say that the response has not been as streamlined as it could be. One senior Biden administration official, speaking anonymously, acknowledged to The New York Times last week that monkeypox testing has not been as fast or convenient as it needs to be. Contributing factors included negotiations with labs, ramping up testing supplies and training personnel, according to the official.

Read original article here

Global arms industry getting shakeup by war in Ukraine – and China and US look like winners from Russia’s stumbles

Russia is losing tanks at an astonishing rate. AP Photo/Emilio Morenatti” src=”https://s.yimg.com/ny/api/res/1.2/m.xJ05Tl1oABWmHrwr6Xpg–/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ2Mg–/https://s.yimg.com/uu/api/res/1.2/3QjLwrtmuyTkFDqWBFiwBA–~B/aD05NDM7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_conversation_us_articles_815/ad20981e646f9c578ba2fa6106607032″ data-src=”https://s.yimg.com/ny/api/res/1.2/m.xJ05Tl1oABWmHrwr6Xpg–/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ2Mg–/https://s.yimg.com/uu/api/res/1.2/3QjLwrtmuyTkFDqWBFiwBA–~B/aD05NDM7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_conversation_us_articles_815/ad20981e646f9c578ba2fa6106607032″/>

Russia’s war in Ukraine is upending the global arms industry.

As the U.S. and its allies pour significant sums of money into arming Ukraine and Russia bleeds tanks and personnel, countries across the world are rethinking defense budgets, materiel needs and military relationships. Countries that historically have had low levels of defense spending such as Japan and Germany are bulking up, while nations that purchase most of their weapons from Russia are questioning their reliability and future delivery.

My research in this area suggests that, however this war eventually ends, the repercussions for the global defense industry, and for the countries whose companies dominate this sector, will be enormous. Here are four takeaways.

1. Russia will be the biggest loser

Russia’s general sales pitch for its weapons has been they’re “cheaper and easier to maintain than Western alternatives.” This is why Russia accounted for 19% of the world’s arms exports from 2017 to 2021, second only to the U.S., which had 39% of the market.

However, this pitch may no longer be effective for many countries that have seen Russian equipment losses and failures in Ukraine.

To date, the U.S. estimates Russia has lost almost a thousand tanks, at least 50 helicopters, 36 fighter-bombers and 350 artillery pieces, according to Business Insider. Thousands of Russian soldiers have been killed, with estimates ranging from about 15,000 to as high as 30,000, and Russia is still unable to control Ukraine’s airspace.

The situation has become so dire that there are reports that commanders are trying to preserve equipment by forbidding troops from using them to evacuate wounded soldiers or to support units that have advanced too far.

Russia’s offensive weapons have also proved disappointing. Its missile failure rate – the share that either failed to launch, malfunctioned mid-flight or missed their target – may be as high as 50% to 60% due to design flaws and outdated or inferior equipment.

These problems, along with the Russian military’s slow progress achieving any of President Vladimir Putin’s stated objectives, have raised serious doubts among the country’s traditional customers for weapons exports. Russia sells almost 90% of its weapons to just 10 countries, including India, Egypt and China.

What’s more, Russia’s ability to replace these equipment losses has been hampered by economic sanctions, which bars key foreign components like circuit boards. And Russia will almost certainly need to replace its own military hardware before it exports anything abroad.

That means that even countries that want to keep buying Russian tanks and fighter jets will have to wait in line or turn elsewhere to fulfill their defense needs.

2. Russia’s loss is China’s gain

The country that will likely see the greatest gains from Russia’s displacement as a major arms supplier is China.

In recent years, the country has taken a 4.6% share of the global arms trade, putting it in fourth place behind France’s 11%. At the same time, seven of the top 20 global defense companies in terms of revenues earned from defense sales are Chinese, signaling the sector’s big ambitions.

Currently, the Chinese government buys most of its weapons and vehicles from these domestic arms makers, but China has the capacity to export more military products abroad.

For example, China is already the world’s largest shipbuilder, so exporting more naval ships is a natural next step. The country is expanding its niche role in drone technology and attempting to leverage modernizing its air force with domestically built aircraft to increase exports.

At the moment, only three of the world’s 40 biggest arms importers – Pakistan, Bangladesh and Myanmar – buy a majority of their weapons from China. That could change if China takes advantage of Russian weakness to position itself as a reliable national security, economic and political partner – a core feature of its Belt and Road Initiative.

China is not capable of supplanting U.S. and European weapons, which are considered “top shelf” because of their high quality and price. But China may well fill the market niche that Russian arms makers dominated, thereby increasing Beijing’s role as a major weapons exporter – and gaining the political and economic benefits that accompany that.

One of China’s biggest challenges will involve proving that its weapons work well in live combat situations.

The U.S. has given Ukraine a third of its Javelin anti-tank missiles. Ukrainian Defense Ministry Press Service via AP” data-src=”https://s.yimg.com/ny/api/res/1.2/UEqCh9SadkTginve8PBdLg–/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNQ–/https://s.yimg.com/uu/api/res/1.2/a5eI8BdRV7Hon5i82JzN_A–~B/aD0wO3c9MDthcHBpZD15dGFjaHlvbg–/https://media.zenfs.com/en/the_conversation_us_articles_815/e5e031264c68fd4129902d4636525b73″/>The U.S. has given Ukraine a third of its Javelin anti-tank missiles. Ukrainian Defense Ministry Press Service via AP” src=”https://s.yimg.com/ny/api/res/1.2/UEqCh9SadkTginve8PBdLg–/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNQ–/https://s.yimg.com/uu/api/res/1.2/a5eI8BdRV7Hon5i82JzN_A–~B/aD0wO3c9MDthcHBpZD15dGFjaHlvbg–/https://media.zenfs.com/en/the_conversation_us_articles_815/e5e031264c68fd4129902d4636525b73″ class=”caas-img”/>

3. American arms makers will also be big winners

U.S. weapons manufactures dominate the global arms industry. The Ukraine war will likely ensure this stays that way for some time.

The world’s five largest arms companies are all American: Lockheed Martin, Raytheon, Boeing, Northrop Grumman and General Dynamics. In fact, half of the top 100 producers of arms are based in the U.S. Twenty are European. Only two are Russian – despite the country being the world’s second-largest source of arms.

The massive amounts of weapons being transferred from the U.S. to Ukraine will keep American arms makers busy for some time to come. For example, the U.S. has transferred about one-third of its stock of Javelin anti-tank missiles to Ukraine, and it will take three to four years for the Raytheon-Lockheed Martin joint venture to replace them. The US billion aid package recently signed by President Joe Biden includes .7 billion to replenish U.S. weapons stocks.

The companies’ soaring stock prices are a sign investors believe profitable days are ahead. Lockheed Martin’s stock price is up over 12% since the invasion began – with most of the gains occurring in its immediate aftermath. Northrop Grumman has jumped 20%. At the same time, the broader stock market as measured by the S&P 500 has slumped about 4%.

4. More countries will become arms makers

The flipside to this is that some countries that relied on others for their defense needs may seek to become more self-sufficient.

India, which relied on Russia for almost half of its weapons imports in recent years, is realizing that Russia will need most or all of its production capacity to replace tanks, missiles, aircraft and other weapons used or lost in Ukraine, with less leftover for export.

That means India will need to either source spare parts for vehicles and weapons from other former Russia arms customers such as Bulgaria, Georgia and Poland, or build up its own defense industry. In April, India announced it would ramp up production of helicopters, tank engines, missiles and early airborne warning systems to offset any potential reduction in Russian exports.

Concerns about Russian reliability are also growing. In May, India canceled a 0 million helicopter deal with Russia. While there are reports U.S. pressure played a role, it also seems to be part of the government’s strategy over the past few years to build its own domestic defense industrial base.

Brazil, Turkey and other emerging market countries have also been developing their own defense industries over the past two decades to reduce their reliance on arms imports. The Ukraine war will accelerate this process.

Putin likely didn’t expect to shake up the global arms market with his effort to annex Ukraine – or cause the decline of his country’s weapons sector. But that’s just one more way his war is causing a geopolitical earthquake.

This article has been updated to correct the size of the canceled Indian helicopter deal.

This article is republished from The Conversation, a nonprofit news site dedicated to sharing ideas from academic experts. It was written by: Terrence Guay, Penn State.

Read more:

Terrence Guay received research funding from the US Army War College, most recently in 2017.

Read original article here

Brazil’s Covid-19 vaccination drive stumbles as Bolsonaro’s disinformation campaign lingers

“There were a lot of young people in the last wave getting worse too fast. We had 33- to 40-year-old patients in the ICU. And we had a bigger limitation of medical supplies. Every day we had a shortage of some kind,” said Dr. Luan Matos de Menezes, an ICU doctor at the Delfina Aziz Hospital in the regional capital of Manaus.

Today, it feels like déjà vu.

As the Omicron coronavirus variant continues to tear through the country at rapid pace, the hospital’s ICU is once again overwhelmed.

But one thing is different, Menezes says. This time, he feels that many of those patients are making a choice.

Although more than 86% of the adult population of Brazil is now fully vaccinated, take-up for boosters has been slow, along with lower rates for younger ages. Some infectious disease experts attribute this to the lingering effects of a disinformation campaign in which the country’s leadership has played a role. Without that protection, those Brazilians have been vulnerable to the latest wave of Omicron infections sweeping the country.

Menezes, who has been working at the hospital throughout the pandemic, says it is harder to have sympathy for these Covid patients. That’s because the majority of the people who are now ending up in the ICU are either unvaccinated or are only partially vaccinated — even though the vaccines have been available to them for months.

More than 80% of people hospitalized with Covid-19 across four Brazilian regional capitals — Rio de Janeiro, Belo Horizonte, Manaus and Brasilia — are either unvaccinated or partially vaccinated, according to local government figures.

And in Manaus, where Menezes works, nine in 10 people admitted to hospital are not fully vaccinated. “These are the people who opted not to vaccinate,” Menezes said.

Menezes also told CNN that many of the unvaccinated patients, who are often already seriously ill when they arrive to the hospital, ask for the vaccine when they are admitted.

But by that point, it is too late.

Brazil has already approaching 640,000 deaths due to the pandemic — the second highest national toll in the world, according to data by Johns Hopkins University.

And this year, the country continues to report record daily Covid-19 cases and deaths. On February 3, the number of daily deaths surpassed 1,000 for the first time since August 2021, according to data from the health ministry.

“Those of us who are at the Covid frontline are seeing a lot of people dying because they did not vaccinate,” said Menezes, who attributes that vaccine hesitancy to “a lot of false information being spread” regarding the vaccines’ efficacy and safety.

Many public health officials are looking at Brazilian President Jair Bolsonaro.

Bolsonaro, who says he is unvaccinated, has been widely criticized at home and abroad for playing down the severity of the virus, with a longstanding campaign to discredit vaccines under his leadership.

Despite this, many Brazilians have taken up the vaccine.

But hesitancy still persists, now reflected in booster shot rates and sluggish uptake rates in younger age groups.

Only 23% of Brazilians ages 12 and older have received their booster dose so far, compared with 94% who have gotten at least one dose.

In younger age groups, those rates drop even lower. Just 10% of children ages 5-11 have gotten the vaccine. They have been eligible to do so since January 17. But some of Bolsonaro’s allies appear set to derail that campaign.

On January 21, Marcelo Queiroga, Brazil’s health minister, and Damares Alves, minister for women and families, visited a family in Sao Paulo state whose child had died of cardiac arrest hours after receiving a Covid-19 vaccine in what some say was an attempt to discredit the vaccine. Sao Paulo’s State Health Secretary said that the child had a rare disease and that her death was not linked to the vaccine.

That same week, Queiroga had falsely claimed that thousands of people had died from adverse reactions caused by the vaccines — directly contradicting his government’s own data. He later said that those comments were taken out of context by the media.

But those comments were already out in the public realm.

Esther Solano, professor of international relations at Sao Paulo University, told CNN that the officials are intentionally creating confusion around vaccines.

“People feel very lost, they don’t know what is true and what is not. It is a strategy of confusion that greatly increases people’s distrust of institutions and the press about what is happening,” Solano said.

Dr. Raquel Stucchi, an infectious disease expert and professor at Unicamp University told CNN that Bolsonaro’s government had delivered “repeated messages questioning efficacy and security” of Covid-19 vaccines, including Bolsonaro himself, who raised the question as to why “one has to take three doses if before two were enough.”

Vaccine boosters and series of doses in vaccines are not unusual. Many vaccines require multiple doses to achieve full immunity, including the polio vaccine, which requires four doses, or the hepatitis vaccine, which requires three. These vaccines are a series, meaning that the second, third or fourth doses are needed to achieve full protection.

Dr. Isabella Ballalai, a pediatrician and vice president of the Brazilian Society of Immunizations, told CNN that Brazilian authorities should be concentrating on positive messaging around vaccines — and making it clear that those who are being hospitalized are largely either unvaccinated or partially vaccinated.

Ballalai cited robust public health messaging in the UK and the US as an example. Brazil’s public health messaging, she said, has been notably weak, with Bolsonaro and his health minister’s vaccine rhetoric only adding to the problem.

As Omicron first began to surge through the country, Bolsonaro claimed that it “hadn’t killed anyone.”

Such language — that Omicron is less harmful — could be contributing to people deciding not to get their booster doses, Stucchi said.

While studies have concluded that the Omicron variant is less likely to cause severe disease and hospitalization compared to the Delta variant, the problem, she said, is that people aren’t connecting the idea that the vaccines themselves are playing a part in ensuring that infections don’t develop into more serious cases.

“People assume that they don’t need to worry much about vaccination anymore. (But) what we know is that Omicron is lighter because of vaccination,” she said.

Ballalai is urging the country’s leaders to send clear and fact-based messaging. It’s the only way to stop the cycle, she said, and to keep future generations safe.

“If you don’t talk about it, Brazilians don’t see the risk. We no longer have the natural demand we saw in the 90s, where everyone looked for a vaccine — so as to not let their children die,” she said.

Read original article here